|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 14-09-16 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 14-09-04 | Roche : rules out mega deals, open to smaller ones - paper | RE |
Executive Committee: InterMune Inc
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 71 | 2002-03-31 | |
Carla Fiankan
LAW | General Counsel | - | 2011-07-31 |
Company details: InterMune Inc
Other Biotechnology & Medical Research
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.46% | +3.72% | -8.59% | -3.21% | 43.24B | |
| +1.73% | +3.59% | +318.08% | +564.04% | 35.25B | |
| +0.61% | +1.34% | +10.00% | +46.20% | 30.22B | |
| +0.02% | -5.93% | +8.45% | -21.44% | 28.01B | |
| -1.06% | -3.71% | +9.08% | +19.56% | 24.08B | |
| -1.23% | +2.11% | - | - | 14.16B | |
| -0.99% | -2.53% | +47.29% | +102.88% | 13.01B | |
| +2.08% | +3.32% | +8.87% | +14.53% | 12.7B | |
| +2.39% | +2.61% | +102.86% | +84.20% | 12.54B | |
| Average | +0.40% | -0.27% | +62.01% | +100.84% | 23.69B | |
| Weighted average by Cap. | +0.54% | -0.20% | +68.41% | +118.51% |
- Stock Market
- Stocks
- Stock
- Company InterMune Inc
Select your edition
All financial news and data tailored to specific country editions
